Patients battling Lysosomal Storage Diseases (LSDs), a group of rare genetic disorders, have reason to be optimistic. The Enzyme Replacement Therapy Market is experiencing significant growth, offering hope for improved treatment options. A recent analysis by Future Market Insights (FMI) reveals a robust market value of USD 10.71 billion in 2024. The future looks even more …